The current state of molecular testing in the treatment of patients with solid tumors, 2019
Top Cited Papers
Open Access
- 22 May 2019
- journal article
- review article
- Published by Wiley in CA: A Cancer Journal for Clinicians
- Vol. 69 (4), 305-343
- https://doi.org/10.3322/caac.21560
Abstract
The world of molecular profiling has undergone revolutionary changes over the last few years as knowledge, technology, and even standard clinical practice have evolved. Broad molecular profiling is now nearly essential for all patients with metastatic solid tumors. New agents have been approved based on molecular testing instead of tumor site of origin. Molecular profiling methodologies have likewise changed such that tests that were performed on patients a few years ago are no longer complete and possibly inaccurate today. As with all rapid change, medical providers can quickly fall behind or struggle to find up‐to‐date sources to ensure he or she provides optimum care. In this review, the authors provide the current state of the art for molecular profiling/precision medicine, practice standards, and a view into the future ahead.Keywords
This publication has 169 references indexed in Scilit:
- Signatures of mutational processes in human cancerNature, 2013
- Personalized Medicine and CancerJournal of Personalized Medicine, 2012
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialThe Lancet, 2012
- KIT as a Therapeutic Target in Metastatic MelanomaJAMA, 2011
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspectiveActa Neuropathologica, 2010
- Understanding resistance to EGFR inhibitors—impact on future treatment strategiesNature Reviews Clinical Oncology, 2010
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Homologous recombination in DNA repair and DNA damage toleranceCell Research, 2008
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007
- Hallmarks of 'BRCAness' in sporadic cancersNature Reviews Cancer, 2004